Application of an electronic nose in the diagnosis of head and neck cancer

Laryngoscope

Volumn 124, Issue 6, 2014, Pages 1377-1381

  Leunis, Nicoline ^a   Boumans, Marie Louise ^a   Kremer, Bernd ^a   Din, Sinh ^a   Stobberingh, Ellen ^a   Kessels, Alfons G H ^a   Kross, Kenneth W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Electronic nose; head and neck cancer; volatile organic compounds

Indexed keywords

METAL OXIDE;

ADULT; AGED; AIR SAMPLING; BREATH ANALYSIS; CANCER DIAGNOSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELECTRONIC NOSE; EXPIRED AIR; FEMALE; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MALE; MEDICAL TECHNOLOGY; OROPHARYNX CANCER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ELECTRONIC NOSE; HEAD AND NECK CANCER; VOLATILE ORGANIC COMPOUNDS;

ADULT; AGED; BREATH TESTS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; ELECTRONIC NOSE; EXHALATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; TERTIARY CARE CENTERS; VOLATILE ORGANIC COMPOUNDS;

EID: 84901687015     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24463     Document Type: Conference Paper

References (36)

1. Marur S, Forastiere AA,. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008; 83: 489-501.
2. Wei WI,. Commentary: head and neck carcinomas in the developing world. BMJ 2002; 325: 827.
3. Johnson N,. Tobacco use and oral cancer: a global perspective. J Dent Educ 2001; 65: 328-339.
4. Mork J, Glattre E,. Squamous cell carcinomas of the head and neck in Norway, 1953-1992: an epidemiologic study of a low-risk population. Cancer Causes Control 1998; 9: 37-48.
5. McMahon S, Chen AY,. Head and neck cancer. Cancer Metastasis Rev 2003; 22: 21-24.
6. de Bree R, van der Putten L, Hoekstra OS, et al. A randomized trial of PET scanning to improve diagnostic yield of direct laryngoscopy in patients with suspicion of recurrent laryngeal carcinoma after radiotherapy. Contemp Clin Trials 2007; 28: 705-712.
7. Zbaren P, Weidner S, Thoeny HC,. Laryngeal and hypopharyngeal carcinomas after (chemo) radiotherapy: a diagnostic dilemma. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 147-153.
8. Pauling L, Robinson AB, Teranishi R, Cary P,. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A 1971; 68: 2374-2376.
9. Persaud K, Dodd G,. Analysis of discrimination mechanisms in the mammalian olfactory system using a model nose. Nature 1982; 299: 352-355.
10. Peris M, Escuder-Gilabert L,. A 21st century technique for food control: electronic noses. Anal Chim Acta 2009; 638: 1-15.
11. Kramer KE, Rose-Pehrsson SL, Hammond MH, Tillett D, Streckert HH,. Detection and classification of gaseous sulfur compounds by solid electrolyte cyclic voltammetry of cermet sensor array. Anal Chim Acta 2007; 584: 78-88.
12. Fernandes DL, Gomes MT,. Development of an electronic nose to identify and quantify volatile hazardous compounds. Talanta 2008; 77: 77-83.
13. Pavlou AK, Magan N, Jones JM, Brown J, Klatser P, Turner AP,. Detection of mycobacterium tuberculosis (TB) in vitro and in situ using an electronic nose in combination with a neural network system. Biosens Bioelectron 2004; 20: 538-544.
14. Fend R, Kolk AH, Bessant C, Buijtels P, Klatser PR, Woodman AC,. Prospects for clinical application of electronic-nose technology to early detection of Mycobacterium tuberculosis in culture and sputum. J Clin Microbiol 2006; 44: 2039-2045.
15. Kolk A, Hoelscher M, Maboko L, et al. Electronic-nose technology using sputum samples in diagnosis of patients with tuberculosis. J Clin Microbiol 2010; 48: 4235-4238.
16. Bruins M, Rahim Z, Bos A, van de Sande WW, Endtz HP, van Belkum A,. Diagnosis of active tuberculosis by e-nose analysis of exhaled air. Tuberculosis (Edinb) 2013; 93: 232-228. doi: 10.1016/j.tube.2012.10.002. Epub 2012.
17. Voss A, Baier V, Reisch R, et al. Smelling renal dysfunction via electronic nose. Ann Biomed Eng 2005; 33: 656-660.
18. Pavlou AK, Magan N, McNulty C, et al. Use of an electronic nose system for diagnoses of urinary tract infections. Biosens Bioelectron 2002; 17: 893-899.
19. Guernion N, Ratcliffe NM, Spencer-Phillips PT, Howe RA,. Identifying bacteria in human urine: current practice and the potential for rapid, near-patient diagnosis by sensing volatile organic compounds. Clin Chem Lab Med 2001; 39: 893-906.
20. Phillips M, Gleeson K, Hughes JM, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999; 353: 1930-1933.
21. Di Natale C, Macagnano A, Martinelli E, et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron 2003; 18: 1209-1218.
22. Hanson CW, 3rd, Thaler ER,. Electronic nose prediction of a clinical pneumonia score: biosensors and microbes. Anesthesiology 2005; 102: 63-68.
23. Hockstein NG, Thaler ER, Lin Y, Lee DD, Hanson CW,. Correlation of pneumonia score with electronic nose signature: A prospective study. Ann Otol Rhinol Laryngol 2005; 114: 504-508.
24. Hockstein NG, Thaler ER, Torigian D, Miller WT Jr, Deffenderfer O, Hanson CW,. Diagnosis of pneumonia with an electronic nose: correlation of vapor signature with chest computed tomography scan findings. Laryngoscope 2004; 114: 1701-1705.
25. Machado RF, Laskowski D, Deffenderfer O, et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 2005; 171: 1286-1291.
26. Chen X, Xu F, Wang Y, et al. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer 2007; 110: 835-844.
27. Gendron KB, Hockstein NG, Thaler ER, Vachani A, Hanson CW,. In vitro discrimination of tumor cell lines with an electronic nose. Otolaryngol Head Neck Surg 2007; 137: 269-273.
28. Dragonieri S, Schot R, Mertens BJ, et al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 2007; 120: 856-862.
29. Dragonieri S, Annema JT, Schot R, et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 2009; 64: 166-170. doi: 10.1016/j.lungcan.2008.08.008. Epub 2008.
30. Fens N, Zwinderman AH, van der Schee MP, et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2009; 180: 1076-1082.
31. D'Amico A, Pennazza G, Santonico M, et al. An investigation on electronic nose diagnosis of lung cancer. Lung Cancer 2010; 68: 170-176.
32. Montuschi P, Santonico M, Mondino C, et al. Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. Chest 2010; 137: 790-796.
33. Shykhon ME, Morgan DW, Dutta R, Hines EL, Gardner JW,. Clinical evaluation of the electronic nose in the diagnosis of ear, nose and throat infection: a preliminary study. J Laryngol Otol 2004; 118: 706-709.
34. Thaler ER, Hanson CW,. Use of an electronic nose to diagnose bacterial sinusitis. Am J Rhinol 2006; 20: 170-172.
35. Bruno E, Alessandrini M, Ottaviani F, et al. Can the electronic nose diagnose chronic rhinosinusitis? A new experimental study. Eur Arch Otorhinolaryngol 2008; 265: 425-428.
36. Schmutzhard J, Rieder J, Deibl M, et al. Pilot study: volatile organic compounds as a diagnostic marker for head and neck tumors. Head Neck 2008; 30: 743-749.